Levetiracetam Desitin

Levetiracetam, the active ingredient in Levetiracetam Desitin, is an anticonvulsant presented as an oral tablet for oral use. It treats partial, generalized tonic‑clonic and myoclonic seizures in patients with epilepsy.

GNH USA supplies Levetiracetam Desitin as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide, with distribution across EU and other regulated markets.

Levetiracetam is an antiepileptic medication used to manage seizure disorders.

- Partial seizures: reduces the frequency of focal onset seizures. - Generalized tonic‑clonic seizures: helps control convulsive episodes. - Myoclonic seizures: decreases the occurrence of rapid muscle jerks.

Levetiracetam may cause a range of adverse reactions, from mild to severe.

Common Side Effects: - Dizziness: transient sensation of light‑headedness. - Fatigue: feeling unusually tired or weak. - Somnolence: increased sleepiness during the day. - Headache: mild to moderate cranial pain. - Irritability: mood changes or agitation. - Nausea: upset stomach or feeling of queasiness.

Serious or Rare Side Effects: - Severe allergic reactions: rash, Stevens‑Johnson syndrome, or anaphylaxis. - Mood alterations: depression, suicidal thoughts, or aggressive behavior. - Blood disorders: leukopenia, thrombocytopenia, or anemia. - Respiratory depression: rare but potentially life‑threatening breathing difficulty. - Hepatic injury: signs of liver dysfunction. - Severe skin reactions: toxic epidermal necrolysis.

When prescribing levetiracetam, clinicians should consider several safety aspects.

- Renal impairment: adjust dose based on creatinine clearance. - Hepatic dysfunction: monitor liver function tests regularly. - Pregnancy: discuss potential risks with the patient; use only if clearly needed. - Concomitant CNS depressants: may increase sedation or respiratory depression. - Mood changes: observe for signs of depression or suicidal ideation. - Store at ambient temperature: keep below 25°C, retain in original packaging, and protect from moisture.

Levetiracetam can interact with other medicines, affecting its efficacy or safety.

Major Interactions (Avoid): - Carbamazepine: enzyme induction may lower levetiracetam plasma levels. - Phenytoin: reduces levetiracetam concentration, potentially decreasing seizure control. - Phenobarbital: may decrease levetiracetam exposure, risking breakthrough seizures.

Moderate Interactions (Monitor Closely): - Valproic acid: may increase the risk of adverse CNS effects. - Alcohol: can enhance sedation and dizziness. - Other antiepileptics: additive CNS depression or altered seizure thresholds may occur.